Bridgewater
BRIDGEWATER, New Jersey, November 29, 2011  -
  
- Engineered around a new second-generation sCMOS detector, the ORCA-Flash4.0 is the first camera that challenges the performance of all CCD, EM-CCD, and first-generation sCMOS cameras for every fluorescence application
Hamamatsu Photonics introduces the new ORCA-Flash4.0 scientific CMOS camera. Featuring exceptional quantum efficiency and low noise, the ORCA-Flash4.0 delivers better signal-to-noise characteristics than EM-CCDs, cooled CCDs, and first-generation scientific CMOS cameras.
                                                                    
                                        BRIDGEWATER, New Jersey, November 1, 2011  -
  
- Listed companies to present at Therapeutic Area Partnerships conference, Boston, November 30 - December 2
Elsevier Business Intelligence and Windhover Conferences today announced the Top Projects to Watch list.
                                                                    
                                        BRIDGEWATER, New Jersey, September 12, 2011  -
  
-- Welsh, Carson, Anderson & Stowe led the financing and assumes a controlling interest in Valeritas
-- Financing will support the commercialization of the V-Go™ Disposable Insulin Delivery Device with a primary focus on adult patients with Type 2 diabetes who require insulin
Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it has completed a significant Series C round of financing of $150 million.
                                                                    
                                        BRIDGEWATER, New Jersey, August 8, 2011  -
  
Elsevier Business Intelligence, the biopharma industry's leading provider of strategic business intelligence and conferences, is hosting Windhover's 21st Pharmaceutical Strategic Alliances (PSA) September 21-23, 2011 at the Millennium Broadway in New York, NY.
                                                                    
                                        BRIDGEWATER, New Jersey, July 25, 2011  -
  
Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it received CE Mark approval for its V-Go™ Disposable Insulin Delivery Device as well as ISO 13485: 2003 Quality Management System Certification.
                                                                    
                                        More News 
                            
                        - Hamamatsu Introduces a New Streak Camera for UV to NIR Measurements
- The New Quantaurus Series Offers Quick, Easy Measurements of the Fluorescence Lifetime and Quantum Yield of Photoluminescent Materials
- Hamamatsu Photonics Introduces the Cost-effective FDSS/uCELL Imaging Plate Reader
- Hamamatsu Introduces the New ORCA-Flash2.8 Scientific CMOS Camera
- Clinical Therapeutics Announces the Addition of Michael G. Spigarelli, MD, PhD, as Editor for a Refocused Pediatric, Adolescent, & Maternal Therapeutics Section
- /C O R R E C T I O N — Clinical Therapeutics/